株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

眼科用医薬品の世界市場

Ophthalmic Pharmaceutical Drugs

発行 Global Industry Analysts, Inc. 商品コード 912463
出版日 ページ情報 英文 250 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
眼科用医薬品の世界市場 Ophthalmic Pharmaceutical Drugs
出版日: 2019年10月01日 ページ情報: 英文 250 Pages
概要

当レポートでは、世界における眼科用医薬品市場の概要、動向・発展への影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション・調査手法・調査範囲

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界の眼科用医薬品市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • ALLERGAN PLC
  • BAYER AG
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON AND JOHNSON VISION CARE INC
  • 協和キリン
  • NOVARTIS INTERNATIONAL AG
  • PFIZER, INC
  • REGENERON PHARMACEUTICALS, INC.
  • 参天製薬
  • SHIRE PLC

第5章 調査資料

目次
Product Code: MCP-1490

Ophthalmic Pharmaceutical Drugs market worldwide is projected to grow by US$9.2 Billion, driven by a compounded growth of 4.5%. Anti-Inflammatory Drugs, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$9 Billion by the year 2025, Anti-Inflammatory Drugs will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$323.1 Million to the region's size and clout in the next 5 to 6 years. Over US$267.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Anti-Inflammatory Drugs will reach a market size of US$450.7 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.1% over the next couple of years and add approximately US$2.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Allergan PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson and Johnson Vision Care Inc; Kyowa Kirin Co., Ltd; Novartis International AG; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Santen Pharmaceuticals Co., Ltd.; Shire PLC

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Ophthalmic Pharmaceutical Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Ophthalmic Pharmaceutical Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Ophthalmic Pharmaceutical Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Ophthalmic Pharmaceutical Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Anti-Inflammatory Drugs (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Anti-Inflammatory Drugs (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Anti-Inflammatory Drugs (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Anti-Infective Drugs (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Anti-Infective Drugs (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Anti-Infective Drugs (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Anti-Glaucoma Drugs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Anti-Glaucoma Drugs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Anti-Glaucoma Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Anti-Allergic Drugs (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Anti-Allergic Drugs (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Anti-Allergic Drugs (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Other Drug Classes (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Other Drug Classes (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Other Drug Classes (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Prescription Drugs (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Prescription Drugs (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Prescription Drugs (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Over-the-Counter Drugs (Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Over-the-Counter Drugs (Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Over-the-Counter Drugs (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Ophthalmic Pharmaceutical Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 25: United States Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 26: Ophthalmic Pharmaceutical Drugs Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 27: United States Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 28: United States Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 29: Ophthalmic Pharmaceutical Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 30: United States Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 31: Canadian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 32: Canadian Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 33: Ophthalmic Pharmaceutical Drugs Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 34: Canadian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 35: Canadian Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 36: Ophthalmic Pharmaceutical Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 37: Japanese Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 38: Ophthalmic Pharmaceutical Drugs Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 39: Japanese Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 40: Japanese Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 41: Ophthalmic Pharmaceutical Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 42: Japanese Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 43: Chinese Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 44: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 45: Chinese Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 46: Chinese Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 47: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 48: Chinese Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Ophthalmic Pharmaceutical Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 49: European Ophthalmic Pharmaceutical Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 50: Ophthalmic Pharmaceutical Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 51: European Ophthalmic Pharmaceutical Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 52: European Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 53: Ophthalmic Pharmaceutical Drugs Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 54: European Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 55: European Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 56: Ophthalmic Pharmaceutical Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 57: European Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 58: Ophthalmic Pharmaceutical Drugs Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 59: French Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 60: French Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 61: Ophthalmic Pharmaceutical Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: French Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 63: French Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 64: Ophthalmic Pharmaceutical Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 65: German Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 66: German Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 67: Ophthalmic Pharmaceutical Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 68: German Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 69: German Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 70: Italian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 71: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 72: Italian Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 73: Italian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 74: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 75: Italian Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 76: United Kingdom Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 77: Ophthalmic Pharmaceutical Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 78: United Kingdom Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 79: United Kingdom Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 80: Ophthalmic Pharmaceutical Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 81: United Kingdom Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 82: Spanish Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 83: Spanish Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 84: Ophthalmic Pharmaceutical Drugs Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 85: Spanish Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 86: Spanish Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 87: Ophthalmic Pharmaceutical Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 88: Russian Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 89: Ophthalmic Pharmaceutical Drugs Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 90: Russian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 91: Russian Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 92: Ophthalmic Pharmaceutical Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 93: Russian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 95: Ophthalmic Pharmaceutical Drugs Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 96: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 97: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 98: Ophthalmic Pharmaceutical Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 99: Rest of Europe Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 100: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 101: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 102: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 103: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 104: Asia-Pacific Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 105: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 106: Ophthalmic Pharmaceutical Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 107: Asia-Pacific Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 108: Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 109: Ophthalmic Pharmaceutical Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 110: Australian Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 111: Australian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 112: Ophthalmic Pharmaceutical Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 113: Australian Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 114: Australian Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 115: Indian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 116: Indian Ophthalmic Pharmaceutical Drugs Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 117: Ophthalmic Pharmaceutical Drugs Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 118: Indian Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 119: Indian Ophthalmic Pharmaceutical Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 120: Ophthalmic Pharmaceutical Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 121: Ophthalmic Pharmaceutical Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 122: South Korean Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 123: Ophthalmic Pharmaceutical Drugs Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 124: Ophthalmic Pharmaceutical Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 125: South Korean Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 126: Ophthalmic Pharmaceutical Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 127: Rest of Asia-Pacific Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 128: Ophthalmic Pharmaceutical Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 129: Rest of Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 130: Rest of Asia-Pacific Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 131: Ophthalmic Pharmaceutical Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 132: Rest of Asia-Pacific Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 133: Latin American Ophthalmic Pharmaceutical Drugs Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 134: Ophthalmic Pharmaceutical Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 135: Latin American Ophthalmic Pharmaceutical Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 136: Latin American Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 137: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 138: Latin American Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 139: Latin American Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 140: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 141: Latin American Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 142: Argentinean Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 143: Ophthalmic Pharmaceutical Drugs Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 144: Argentinean Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 145: Argentinean Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 146: Ophthalmic Pharmaceutical Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 147: Argentinean Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 148: Ophthalmic Pharmaceutical Drugs Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 149: Brazilian Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 150: Brazilian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 151: Ophthalmic Pharmaceutical Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 152: Brazilian Ophthalmic Pharmaceutical Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 153: Brazilian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 154: Ophthalmic Pharmaceutical Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 155: Mexican Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 156: Mexican Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 157: Ophthalmic Pharmaceutical Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 158: Mexican Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 159: Mexican Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 160: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 161: Ophthalmic Pharmaceutical Drugs Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 162: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 163: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 164: Ophthalmic Pharmaceutical Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 165: Rest of Latin America Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 166: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 167: Ophthalmic Pharmaceutical Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 168: The Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 169: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 170: The Middle East Ophthalmic Pharmaceutical Drugs Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 171: Ophthalmic Pharmaceutical Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 172: The Middle East Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 173: The Middle East Ophthalmic Pharmaceutical Drugs Historic Market by Type in US$ Million: 2009-2017
    • TABLE 174: Ophthalmic Pharmaceutical Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 175: Iranian Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 176: Ophthalmic Pharmaceutical Drugs Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 177: Iranian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 178: Iranian Market for Ophthalmic Pharmaceutical Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 179: Ophthalmic Pharmaceutical Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 180: Iranian Ophthalmic Pharmaceutical Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 181: Israeli Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 182: Ophthalmic Pharmaceutical Drugs Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 183: Israeli Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 184: Israeli Ophthalmic Pharmaceutical Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 185: Ophthalmic Pharmaceutical Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 186: Israeli Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 187: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 188: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 189: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 190: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 191: Ophthalmic Pharmaceutical Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 192: Saudi Arabian Ophthalmic Pharmaceutical Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 193: Ophthalmic Pharmaceutical Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 194: United Arab Emirates Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 195: Ophthalmic Pharmaceutical Drugs Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 196: Ophthalmic Pharmaceutical Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 197: United Arab Emirates Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 198: Ophthalmic Pharmaceutical Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 199: Ophthalmic Pharmaceutical Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 200: Rest of Middle East Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 201: Rest of Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 202: Ophthalmic Pharmaceutical Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 203: Rest of Middle East Ophthalmic Pharmaceutical Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 204: Rest of Middle East Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 205: African Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 206: Ophthalmic Pharmaceutical Drugs Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 207: African Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 208: African Ophthalmic Pharmaceutical Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 209: Ophthalmic Pharmaceutical Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 210: African Ophthalmic Pharmaceutical Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ALLERGAN PLC
  • BAYER AG
  • F. HOFFMANN-LA ROCHE AG
  • JOHNSON AND JOHNSON VISION CARE INC
  • KYOWA KIRIN CO., LTD
  • NOVARTIS INTERNATIONAL AG
  • PFIZER, INC
  • REGENERON PHARMACEUTICALS, INC.
  • SANTEN PHARMACEUTICALS CO., LTD.
  • SHIRE PLC

V. CURATED RESEARCH

Back to Top